Evidence map›Paper›PMID 42538907›Full record

ArticlebioRxiv : the preprint server for biology2026

Harmonized nucleoside mass spectrometry enables reproducible cross-platform RNA modification quantification.

Jan Felix Dalwigk, Kira Kerkhoff, Oskar Knittelfelder, Robert L Ross, Maria Cristina Petrella, Anna Kuśnierczyk, Tulsi Bhandari, Aurore Attina, Alicia Burkard, Carolina Brás-Costa and 26 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Jan Felix DalwigkGoethe University Frankfurt, Institute of Pharmaceutical Chemistry, Max-von-Laue-Str. 9, 60438 Frankfurt, Germany.
Kira KerkhoffGoethe University Frankfurt, Institute of Pharmaceutical Chemistry, Max-von-Laue-Str. 9, 60438 Frankfurt, Germany.
Oskar KnittelfelderBruker Daltonics GmbH & Co. KG, Fahrenheitstr. 4, 28359 Bremen, Germany.
Robert L RossThermo Fisher Scientific, 10 Maguire Ave., Lexington, MA 01450.ORCID 0000-0001-8710-3675
Maria Cristina PetrellaCentre for Genomic Regulation (CRG), The Barcelona Institue of Science and Technology, Dr Aiguader 88, Barcelona 08003, Spain.
Anna KuśnierczykUniversity of Bern, Swiss RNA Mass Spectrometry Platform, Department of Chemistry, Biochemistry and Pharmaceutical Sciences, Freiestrasse 3, 3012 Bern, Switzerland.
Tulsi BhandariRieveschl Laboratories for Mass Spectrometry, Department of Chemistry, University of Cincinnati, Cincinnati, Ohio 45221, United States.
Aurore AttinaIRMB-PPC, Univ Montpellier, INSERM, CHU Montpellier, CNRS, Montpellier, France. Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Univ. Montpellier, Institut régional du Cancer de Montpellier (ICM), Montpellier, France.
Alicia BurkardJohannes Gutenberg-Universität, Institute of Pharmaceutical and Biomedical Sciences, Staudingerweg 5, 55128 Mainz, Germany.
Carolina Brás-CostaDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, United States.
Michael S DeMottMassachusetts Institute of Technology, Department of Biological Engineering, Cambridge, MA 02139, United States.
Kitty JohnsonPhillips University Marburg, Department of Pharmacy, Institute for Pharmaceutical Biology and Biotechnology, 35037 Marburg, Germany.
Xenia Kerkhoff-BernaciakTU Dortmund University, Department of Mathematics, Vogelpothsweg 87, 44227 Dortmund, Germany.
Jennifer KistRieveschl Laboratories for Mass Spectrometry, Department of Chemistry, University of Cincinnati, Cincinnati, Ohio 45221, United States.
Ken KögelLudwigs-Maximilians-University Munich, Department of Chemistry, Institute of Chemical Epigenetics, Butenandtstraße 5-13, 81377 Munich Germany.
Martina KrämerJohannes Gutenberg-Universität, Institute of Pharmaceutical and Biomedical Sciences, Staudingerweg 5, 55128 Mainz, Germany.
Ricardo Moreno-BallesterosUniversity of Dundee, School of Life Sciences, Protein Phosphorylation and Ubiquitylation Unit, Dow Street, DD1 5EH Dundee, United Kingdom.
Ganna PodoprygorinaIRMB-PPC, Univ Montpellier, INSERM, CHU Montpellier, CNRS, Montpellier, France. Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Univ. Montpellier, Institut régional du Cancer de Montpellier (ICM), Montpellier, France.
Kaley SimcoxUniversity of Michigan, Department of Chemistry, Ann Arbor, MI 48109, United States.
Özge SimsirLudwigs-Maximilians-University Munich, Department of Chemistry, Institute of Chemical Epigenetics, Butenandtstraße 5-13, 81377 Munich Germany.
Anton SkribaCzech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo náměstí 2, Prague 6, Czechia.
Sam WeinUniversity of Tuebingen, Department of Computer Science, Maria-von-Linden-Straße 6, 72076 Tübingen.
Hana CahovaCzech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Flemingovo náměstí 2, Prague 6, Czechia.
Benjamin A GarciaDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, United States.
Mark HelmJohannes Gutenberg-Universität, Institute of Pharmaceutical and Biomedical Sciences, Staudingerweg 5, 55128 Mainz, Germany.ORCID 0000-0002-0154-0928
Alexandre DavidIRMB-PPC, Univ Montpellier, INSERM, CHU Montpellier, CNRS, Montpellier, France. Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Univ. Montpellier, Institut régional du Cancer de Montpellier (ICM), Montpellier, France.
Katharina HöferPhillips University Marburg, Department of Pharmacy, Institute for Pharmaceutical Biology and Biotechnology, 35037 Marburg, Germany.
Sebastian LeidelUniversity of Bern, Swiss RNA Mass Spectrometry Platform, Department of Chemistry, Biochemistry and Pharmaceutical Sciences, Freiestrasse 3, 3012 Bern, Switzerland.ORCID 0000-0002-0523-6325
Patrick A LimbachRieveschl Laboratories for Mass Spectrometry, Department of Chemistry, University of Cincinnati, Cincinnati, Ohio 45221, United States.
Eva NovoaCentre for Genomic Regulation (CRG), The Barcelona Institue of Science and Technology, Dr Aiguader 88, Barcelona 08003, Spain.
Eduard SabidóCentre for Genomic Regulation (CRG), The Barcelona Institue of Science and Technology, Dr Aiguader 88, Barcelona 08003, Spain.
Sabine SchneiderLudwigs-Maximilians-University Munich, Department of Chemistry, Institute of Chemical Epigenetics, Butenandtstraße 5-13, 81377 Munich Germany.ORCID 0000-0003-1054-8689
Philippe WolffUniversité de Strasbourg, CNRS, Architecture et Réactivité de lÁRN, 67084 Strasbourg, France.
Peter DedonMassachusetts Institute of Technology, Department of Biological Engineering, Cambridge, MA 02139, United States.ORCID 0000-0003-0011-3067
Vivian CheungBrown University. Department of Molecular Biology, Cell Biology and Biochemistry, 70 Ship Street, Providence, RI 02903, United States.ORCID 0000-0002-4029-6243
Stefanie KaiserGoethe University Frankfurt, Institute of Pharmaceutical Chemistry, Max-von-Laue-Str. 9, 60438 Frankfurt, Germany.

Funding

Viral modulation of epitranscriptomic mechanismsR01AI118891 · NIAID · WASHINGTON UNIVERSITY · PI GARCIA, BENJAMIN A, WEITZMAN, MATTHEW D. · 2015 to 2025
$5.4M
MFB: Integrating LC-MS/MS and Nanopore Sequencing Platforms to Enable the Direct and Quantatative Detection of RNA ModificationsR01HG013876 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Kristin S Koutmou · 2024 to 2026
$1.2M
NHGRI NIH HHS R01 HG013876NIAID NIH HHS R01 AI118891
6 · The paper itself

Abstract

RNA modification analysis by LC-MS/MS is central to epitranscriptomics, yet quantitative comparison across laboratories and instrument platforms remains poorly standardized. Here, we performed a community-driven benchmarking study during the first Human RNome Project workshop to systematically evaluate cross-platform reproducibility of ribonucleoside mass spectrometry workflows. Using the same analytical column and gradient, standardized RNA samples, and shared reagents, we compared nucleoside quantification across quadrupole, time-of-flight, and orbitrap-based LC-MS platforms employing distinct acquisition strategies. While chromatographic separation was highly reproducible across systems, nucleoside-specific MS response behavior differed substantially between platforms and limited direct comparability of relative signal intensities. These response differences varied across analytes and concentration ranges, demonstrating that harmonized chromatography alone is insufficient for transferable quantitative analysis. Stable isotope-labeled internal standard (SILIS) normalization substantially reduced platform- and method-dependent response and improved agreement for most evaluated modifications. External calibration improved agreement between qTOF and Orbitrap workflows for a subset of modifications but did not fully resolve residual intersystem differences. Based on these findings, we establish benchmark-derived recommendations for harmonized relative and absolute RNA modification quantification, including guidance for calibration design, quality control, and data reporting. Together, this work provides a methodological framework for reproducible nucleoside LC-MS/MS workflows and establishes a foundation for large-scale comparative epitranscriptomic studies.

Identifiers

PMID42538907
PMCPMC13419381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.